Alleviation of accelerated diabetic atherogenesis in STZ-treated apoE/NOX1 DKO mice, apoE-/-/tg-EC-DHFR mice, and by folic acid

By sjmartinez • April 6, 2025

Zhang Y, Youn JY, Huang K, Zhang Y, Cai H. Alleviation of accelerated diabetic atherogenesis in STZ-treated apoE/NOX1 DKO mice, apoE^-/-/tg-EC-DHFR mice, and by folic acid. Redox Biol. 2025 Feb 27;82:103570. doi: 10.1016/j.redox.2025.103570. Epub ahead of print. PMID: 40184644.

Atherosclerosis, Diabetes, Diabetic atherogenesis, Dihydrofolate reductase, DHFR, Endothelial nitric oxide synthase, eNOS, uncoupling, Endothelial-specific DHFR transgenic mice, tg-EC-DHFR, NADPH oxidase isoform 1, NOX1, NOX1 knockout mice, apoE(-/-)/NOX1(-/y), apoE null mice, apoE(−/−), apoE/NOX1 double knockout mice, apoE(-/-)/NOX1(-/y),

Tags: apoE null mice, apoE(-/-)/NOX1(-/y), apoE(−/−), apoE/NOX1 double knockout mice, Atherosclerosis, Cardiology/Epi, DHFR, diabetes, Diabetic atherogenesis, Dihydrofolate reductase, Endothelial nitric oxide synthase, Endothelial-specific DHFR transgenic mice, eNOS, NADPH oxidase isoform 1, NOX1, NOX1 knockout mice, Post Doc, Publications, tg-EC-DHFR, Uncoupling

Large-bore mechanical thrombectomy vs standard of care for acute high-risk pulmonary embolism: rationale and design of the PERSEVERE randomized controlled trial

Chopard R, Hobohm L, Barco S, Bangalore S, Giri J, Mahfoud F, Moriarty J, Rosenkranz S, Sharp A, Thiele H, Toma C, Tapson VF, Markovitz[...]

Trends and Projections in Hypertension-Related Mortality in the United States: A 1979-2050 CDC WONDER Analysis

Ahmed M, Abbas F, Khan S, Qureshi S, Khan GT, Shafiq SB, Imran W, Waqas SA, Fudim M, Fonarow GC, Greene SJ, Khan MS. Trends[...]

Public Health

Xu H, Grory BCM, Ikeaba U, Alhanti B, Fonarow GC, Schwamm LH, Smith EE, Messe SR, Ostbye T, De Lemos JA, Peterson ED, Xian Y.[...]